KYNB

Kyntra Bio Inc

$6.79

0.11 (1.59%) Today

— up— down

Compare KYNB

Market Cap

$27M-44.9%

Revenue (TTM)

$4.62M-91.4%

Net Income (TTM)

$183.47M

EPS (TTM)

45.30

Shares Out

4.05M

P/E Ratio

0.15

Open

$6.79

Previous Close

$6.90

Day Range

$6.64 – $6.95

52-Week Range

$6.32 – $12.46

Beta

1.03

Volume

18.05K

Avg Volume

20.38K

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About KYNB

Kyntra Bio, Inc. is a biopharmaceutical company headquartered in San Francisco, California. Once regarded as a promising developer of innovative therapies for anemia and fibrotic diseases, with a market capitalization of roughly $4 billion in 2018–19, the company's value collapsed following late-stage trial failures, regulatory setbacks, and a data manipulation scandal. By 2026, Kyntra was mainly reduced to a single early-stage oncology drug candidate.